Maintaining Uninterrupted Drug Supply In The Midst Of Product Relabeling

The business challenge: Optimizing the drug supply while relabeling depot inventory.

Expiry date updates are commonplace as product stability profiles are often developing, concurrent to the conduct of clinical trials. Expiry date extensions often result in relabeling activities at depots and sites throughout the distribution network. These are activities which must be carefully planned and monitored to ensure there is no disruption to patient activities due to insufficiently labelled supplies.